Cargando…
Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicry
Influenza viruses possess a great threat to human health, but there is still no effective drug to deal with the outbreak of possible new influenza subtypes. In this study, we first fractionated sialylated immunoglobulin G (IgG), mainly Fab sialylated fraction, with sambucus nigra agglutinin affinity...
Autores principales: | Huang, Tao, Chen, Xueling, Zhao, Conghui, Liu, Xingmu, Zhang, Zaiping, Li, Tongfei, Sun, Ruiman, Gu, Huan, Gu, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941264/ https://www.ncbi.nlm.nih.gov/pubmed/26870994 http://dx.doi.org/10.18632/oncotarget.7244 |
Ejemplares similares
-
Fractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the molecule
por: Huang, Tao, et al.
Publicado: (2016) -
Immunoglobulin G promotes skin graft acceptance in an immunologically potent rat model
por: Liu, Xingmu, et al.
Publicado: (2016) -
Infectious Progeny of 2009 A (H1N1) Influenza Virus Replicated in and Released from Human Neutrophils
por: Zhang, Zhang, et al.
Publicado: (2015) -
Nonspecific immunoglobulin G is effective in preventing and treating cancer in mice
por: Xu, Qian, et al.
Publicado: (2019) -
Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases
por: Li, Danqi, et al.
Publicado: (2021)